JP2022545387A5 - - Google Patents
Info
- Publication number
- JP2022545387A5 JP2022545387A5 JP2022509196A JP2022509196A JP2022545387A5 JP 2022545387 A5 JP2022545387 A5 JP 2022545387A5 JP 2022509196 A JP2022509196 A JP 2022509196A JP 2022509196 A JP2022509196 A JP 2022509196A JP 2022545387 A5 JP2022545387 A5 JP 2022545387A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- entrectinib
- administration
- grade
- severity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962886948P | 2019-08-14 | 2019-08-14 | |
| US62/886,948 | 2019-08-14 | ||
| PCT/US2020/046229 WO2021030619A1 (en) | 2019-08-14 | 2020-08-13 | Methods of treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545387A JP2022545387A (ja) | 2022-10-27 |
| JP2022545387A5 true JP2022545387A5 (enExample) | 2023-08-18 |
Family
ID=72266851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509196A Pending JP2022545387A (ja) | 2019-08-14 | 2020-08-13 | がんの処置方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220257592A1 (enExample) |
| EP (1) | EP4013404A1 (enExample) |
| JP (1) | JP2022545387A (enExample) |
| CN (1) | CN114222576A (enExample) |
| TW (1) | TW202114676A (enExample) |
| WO (1) | WO2021030619A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023230454A1 (en) * | 2022-05-24 | 2023-11-30 | Icahn School Of Medicine At Mount Sinai | Neurotrophic tyrosine receptor kinase inhibitors as therapeutics for liver disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8299057B2 (en) | 2007-07-20 | 2012-10-30 | Nerviano Medical Sciences S.R.L. | Substituted indazole derivatives active as kinase inhibitors |
| KR20230169457A (ko) * | 2017-01-27 | 2023-12-15 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
-
2020
- 2020-08-13 TW TW109127558A patent/TW202114676A/zh unknown
- 2020-08-13 EP EP20764225.7A patent/EP4013404A1/en active Pending
- 2020-08-13 CN CN202080057121.3A patent/CN114222576A/zh active Pending
- 2020-08-13 WO PCT/US2020/046229 patent/WO2021030619A1/en not_active Ceased
- 2020-08-13 JP JP2022509196A patent/JP2022545387A/ja active Pending
-
2022
- 2022-02-01 US US17/590,603 patent/US20220257592A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee | Intracerebral hemorrhage | |
| BR112021015129A2 (pt) | Método para tratar um paciente que sofre de hipercortisolemia e um sintoma ou comorbidade da mesma | |
| EP2891499A1 (en) | Combination of sglt2 inhibitor and anti-hypertension drug | |
| EP4164624A1 (en) | Methods for treating or preventing chronic kidney disease | |
| JP5745526B2 (ja) | 糖尿病の予防のためのスルホンアミド | |
| WO2021238957A1 (zh) | 法米替尼在制备用于治疗c-KIT或PDGFRA突变的肿瘤的药物中的用途 | |
| Bonvini et al. | Sinus arrest and moderate hyperkalemia | |
| KR20170125927A (ko) | 골밀도의 조절 방법 | |
| Ellis et al. | Bell's palsy in an older patient with uncontrolled hypertension due to medication nonadherence | |
| TW202440099A (zh) | 治療胃腸道基質瘤方法 | |
| Zhong et al. | Positive inotropic drugs and drugs used in dysrhythmias | |
| Guo | Acute allograft renal failure with marked hyperuricemia developing during mizoribine administration: a case report with review of the literature | |
| Thaper et al. | Progression of ECG in hydroxychloroquine overdose | |
| McNierney et al. | SUN-915 diffuse large B cell lymphoma presents with femur fracture and involvement of thyroid gland | |
| CN113226374B (zh) | 含氨氯地平、氯噻酮和醛固酮受体拮抗剂的药物组合物 | |
| Azizi et al. | Resistant Hypertension | |
| Valentino et al. | Digoxin toxicity caused by an interaction with the novel hepatitis C medication ledipasvir/sofosbuvir | |
| WO2025256469A1 (zh) | 一种药物组合物及其应用 | |
| Mahfoud et al. | RENAL DENERVATION IMPROVES GLUCOSE METABOLISM IN PATIENTS WITH RESISTANT HYPERTENSION: 5A. 02 | |
| CN116648445A (zh) | 治疗或预防慢性肾脏病的方法 | |
| WO2025056075A1 (zh) | 一种用于逆转苄异喹啉类肌松药的肌松拮抗药物 | |
| CN120284970A (zh) | Cb-839在制备治疗糖尿病肾脏病药物中的应用 | |
| Nozaki et al. | Results of unilateral adrenalectomy in subclinical C ushing's syndrome due to adrenocorticotropic hormone‐independent macronodular adrenal hyperplasia | |
| Jaejin et al. | CARDIOVASCULAR OUTCOMES AND ALL-CAUSE MORTALITY ASSOCIATED WITH APPARENT TREATMENT-RESISTANT HYPERTENSION APPLYING THE 2017 ACC/AHA GUIDELINE | |
| CA3241884A1 (en) | Levonorgestrel butanoate formulation and methods relating thereto |